Acute Invasive Fungal Rhinosinusitis: Insights on... (2025 study) Skip to main content
Cohort Study Cureus 2025

Acute Invasive Fungal Rhinosinusitis: Insights on Mortality and Surgical Outcomes From a Cohort Study

Andrade A, Sousa P, Almeida J, Vaz R, Coutinho G, Cureus, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Doctors reviewed the records of 13 patients treated for a fast-moving fungal sinus infection called acute invasive fungal rhinosinusitis between 2013 and 2024.

What They Found

This retrospective cohort study of 13 patients found an overall mortality rate of 53.8%, with 38.5% of deaths directly caused by the infection. Most patients had diabetes or a blood cancer as an underlying condition, and the most common fungal causes were Aspergillus and Mucorales species (six cases each). Orbital invasion occurred in 10 patients and spread to the cavernous sinus in five. Four patients had surgical removal of the eye (orbital exenteration) and survived, and three patients received hyperbaric oxygen therapy alongside their other treatment, with no deaths reported among that group.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a small, retrospective study of only 13 patients with no comparison group, so it cannot show whether hyperbaric oxygen therapy or any single treatment affected survival.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Cohort Study
Category Infection
Source Pubmed
PubMed ID 41069874
Year Published 2025
Journal Cureus

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology